Jazz Pharmaceuticals
JAZZ
JAZZ
466 hedge funds and large institutions have $8.87B invested in Jazz Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 144 increasing their positions, 165 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.13% less ownership
Funds ownership: 91.96% → 91.83% (-0.13%)
13% less repeat investments, than reductions
Existing positions increased: 144 | Existing positions reduced: 165
54% less call options, than puts
Call options by funds: $20.3M | Put options by funds: $44M
Holders
466
Holding in Top 10
10
Calls
$20.3M
Puts
$44M
Top Buyers
| 1 | +$92.2M | |
| 2 | +$58.9M | |
| 3 | +$41.2M | |
| 4 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
+$37.5M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$34.6M |
Top Sellers
| 1 | -$80.2M | |
| 2 | -$57.6M | |
| 3 | -$28.5M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$26.6M |
| 5 |
MDSL
M.D. Sass LLC
New York
|
-$25.3M |